Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach
2012 · Archives of Toxicology · 235 citations
https://doi.org/10.1007/s00204-012-0967-3
J
John Antonydas Gaspar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
1.3K
Citations
19
h-index
23
i10-index
John Antonydas Gaspar is an academic researcher. The author has contributed to research in topics: Pluripotent Stem Cells Research & CRISPR and Genetic Engineering & Epigenetics and DNA Methylation. The author has an h-index of 19, co-authored 30 publications.
Papers by this author
worksMicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
2016 · Archives of Toxicology · 90 citations
https://doi.org/10.1007/s00204-016-1668-0
Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests
2016 · Archives of Toxicology · 57 citations
https://doi.org/10.1007/s00204-016-1741-8
Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: Effects of CREB pathway inhibition
2014 · Toxicology and Applied Pharmacology · 50 citations
https://doi.org/10.1016/j.taap.2014.08.007
Gene profiling of embryonic skeletal muscle lacking type I ryanodine receptor Ca2+ release channel
2016 · Scientific Reports · 23 citations
https://doi.org/10.1038/srep20050
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat